Panretin (Pan-RET-in, alitretinoin) gel, the first TOPICAL treatment for Kaposi's sarcoma
April 1999
The FDA just approved Panretin (Pan-RET-in, alitretinoin) gel, the first TOPICAL treatment for Kaposi's sarcoma.
Alitretinoin is a form of retinoic acid.
It's applied to skin lesions to inhibit cell growth...it doesn't prevent new lesions or treat systemic disease.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote